Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014

Theresa M. Hunter, Natalie N. Boytsov, Xiang Zhang, Krista Schroeder, Kaleb D Michaud, Andre B. Araujo

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

This study aimed to determine the prevalence of rheumatoid arthritis in the United States (US) adult insured population from 2004 to 2014. This was an observational, retrospective, cross-sectional study based on US administrative health insurance claims databases (Truven Health MarketScan® Research database and IMS PharMetrics Plus database). Trends in RA prevalence focusing on the 10-year period covering January 1, 2004–December 31, 2014 were analyzed using a validated algorithm for the identification of RA. Prevalence rates in the databases were determined and age- and gender-adjusted rates were projected to the US population in 2014. Analysis of data from the two databases indicated that the RA prevalence rate in commercially insured adult US population ranged from 0.41 to 0.54% from 2004 to 2014. The prevalence varied substantially by gender and age in each year and increased gradually across the years for most subgroups. In 2014, out of 31,316,902 adult patients with continuous enrollment in the Truven Health MarketScan® Research database, 157,634 (0.50%) patients met our criteria for RA. Similarly, out of 35,083,356 adult patients in the IMS PharMetrics Plus database, 139,300 (0.50%) patients met our criteria for RA. In 2014, the overall age-adjusted prevalence of RA ranged from 0.53 to 0.55% (0.29–0.31% for males and 0.73–0.78% for females). The prevalence of RA in the US appeared to increase during the period from 2004 to 2014, affecting a conservative estimate of 1.28–1.36 million adults in 2014.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalRheumatology International
DOIs
StateAccepted/In press - Apr 28 2017

Fingerprint

Rheumatoid Arthritis
Databases
Delivery of Health Care
Population
Health
Health Insurance
Research
Cross-Sectional Studies

Keywords

  • Claims databases
  • Prevalence
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014. / Hunter, Theresa M.; Boytsov, Natalie N.; Zhang, Xiang; Schroeder, Krista; Michaud, Kaleb D; Araujo, Andre B.

In: Rheumatology International, 28.04.2017, p. 1-7.

Research output: Contribution to journalArticle

Hunter, Theresa M. ; Boytsov, Natalie N. ; Zhang, Xiang ; Schroeder, Krista ; Michaud, Kaleb D ; Araujo, Andre B. / Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014. In: Rheumatology International. 2017 ; pp. 1-7.
@article{e8f0f91580fc470abc9fd25cf82d6589,
title = "Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014",
abstract = "This study aimed to determine the prevalence of rheumatoid arthritis in the United States (US) adult insured population from 2004 to 2014. This was an observational, retrospective, cross-sectional study based on US administrative health insurance claims databases (Truven Health MarketScan{\circledR} Research database and IMS PharMetrics Plus database). Trends in RA prevalence focusing on the 10-year period covering January 1, 2004–December 31, 2014 were analyzed using a validated algorithm for the identification of RA. Prevalence rates in the databases were determined and age- and gender-adjusted rates were projected to the US population in 2014. Analysis of data from the two databases indicated that the RA prevalence rate in commercially insured adult US population ranged from 0.41 to 0.54{\%} from 2004 to 2014. The prevalence varied substantially by gender and age in each year and increased gradually across the years for most subgroups. In 2014, out of 31,316,902 adult patients with continuous enrollment in the Truven Health MarketScan{\circledR} Research database, 157,634 (0.50{\%}) patients met our criteria for RA. Similarly, out of 35,083,356 adult patients in the IMS PharMetrics Plus database, 139,300 (0.50{\%}) patients met our criteria for RA. In 2014, the overall age-adjusted prevalence of RA ranged from 0.53 to 0.55{\%} (0.29–0.31{\%} for males and 0.73–0.78{\%} for females). The prevalence of RA in the US appeared to increase during the period from 2004 to 2014, affecting a conservative estimate of 1.28–1.36 million adults in 2014.",
keywords = "Claims databases, Prevalence, Rheumatoid arthritis",
author = "Hunter, {Theresa M.} and Boytsov, {Natalie N.} and Xiang Zhang and Krista Schroeder and Michaud, {Kaleb D} and Araujo, {Andre B.}",
year = "2017",
month = "4",
day = "28",
doi = "10.1007/s00296-017-3726-1",
language = "English (US)",
pages = "1--7",
journal = "Rheumatology International",
issn = "0172-8172",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014

AU - Hunter, Theresa M.

AU - Boytsov, Natalie N.

AU - Zhang, Xiang

AU - Schroeder, Krista

AU - Michaud, Kaleb D

AU - Araujo, Andre B.

PY - 2017/4/28

Y1 - 2017/4/28

N2 - This study aimed to determine the prevalence of rheumatoid arthritis in the United States (US) adult insured population from 2004 to 2014. This was an observational, retrospective, cross-sectional study based on US administrative health insurance claims databases (Truven Health MarketScan® Research database and IMS PharMetrics Plus database). Trends in RA prevalence focusing on the 10-year period covering January 1, 2004–December 31, 2014 were analyzed using a validated algorithm for the identification of RA. Prevalence rates in the databases were determined and age- and gender-adjusted rates were projected to the US population in 2014. Analysis of data from the two databases indicated that the RA prevalence rate in commercially insured adult US population ranged from 0.41 to 0.54% from 2004 to 2014. The prevalence varied substantially by gender and age in each year and increased gradually across the years for most subgroups. In 2014, out of 31,316,902 adult patients with continuous enrollment in the Truven Health MarketScan® Research database, 157,634 (0.50%) patients met our criteria for RA. Similarly, out of 35,083,356 adult patients in the IMS PharMetrics Plus database, 139,300 (0.50%) patients met our criteria for RA. In 2014, the overall age-adjusted prevalence of RA ranged from 0.53 to 0.55% (0.29–0.31% for males and 0.73–0.78% for females). The prevalence of RA in the US appeared to increase during the period from 2004 to 2014, affecting a conservative estimate of 1.28–1.36 million adults in 2014.

AB - This study aimed to determine the prevalence of rheumatoid arthritis in the United States (US) adult insured population from 2004 to 2014. This was an observational, retrospective, cross-sectional study based on US administrative health insurance claims databases (Truven Health MarketScan® Research database and IMS PharMetrics Plus database). Trends in RA prevalence focusing on the 10-year period covering January 1, 2004–December 31, 2014 were analyzed using a validated algorithm for the identification of RA. Prevalence rates in the databases were determined and age- and gender-adjusted rates were projected to the US population in 2014. Analysis of data from the two databases indicated that the RA prevalence rate in commercially insured adult US population ranged from 0.41 to 0.54% from 2004 to 2014. The prevalence varied substantially by gender and age in each year and increased gradually across the years for most subgroups. In 2014, out of 31,316,902 adult patients with continuous enrollment in the Truven Health MarketScan® Research database, 157,634 (0.50%) patients met our criteria for RA. Similarly, out of 35,083,356 adult patients in the IMS PharMetrics Plus database, 139,300 (0.50%) patients met our criteria for RA. In 2014, the overall age-adjusted prevalence of RA ranged from 0.53 to 0.55% (0.29–0.31% for males and 0.73–0.78% for females). The prevalence of RA in the US appeared to increase during the period from 2004 to 2014, affecting a conservative estimate of 1.28–1.36 million adults in 2014.

KW - Claims databases

KW - Prevalence

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=85018357167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018357167&partnerID=8YFLogxK

U2 - 10.1007/s00296-017-3726-1

DO - 10.1007/s00296-017-3726-1

M3 - Article

SP - 1

EP - 7

JO - Rheumatology International

JF - Rheumatology International

SN - 0172-8172

ER -